[go: up one dir, main page]

AU2001284242A1 - Substituted pyrimidines as selective cyclooxygenase-2 inhibitors - Google Patents

Substituted pyrimidines as selective cyclooxygenase-2 inhibitors

Info

Publication number
AU2001284242A1
AU2001284242A1 AU2001284242A AU8424201A AU2001284242A1 AU 2001284242 A1 AU2001284242 A1 AU 2001284242A1 AU 2001284242 A AU2001284242 A AU 2001284242A AU 8424201 A AU8424201 A AU 8424201A AU 2001284242 A1 AU2001284242 A1 AU 2001284242A1
Authority
AU
Australia
Prior art keywords
inhibitors
substituted pyrimidines
selective cyclooxygenase
cyclooxygenase
selective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284242A
Inventor
Malcolm Clive Carter
Alan Naylor
Martin Pass
Jeremy John Payne
Neil Anthony Pegg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001284242A1 publication Critical patent/AU2001284242A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2001284242A 2000-09-01 2001-08-31 Substituted pyrimidines as selective cyclooxygenase-2 inhibitors Abandoned AU2001284242A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0021494.0A GB0021494D0 (en) 2000-09-01 2000-09-01 Chemical comkpounds
GB0021494 2000-09-01
PCT/GB2001/003935 WO2002018374A1 (en) 2000-09-01 2001-08-31 Substituted pyrimidines as selective cyclooxygenase-2 inhibitors

Publications (1)

Publication Number Publication Date
AU2001284242A1 true AU2001284242A1 (en) 2002-03-13

Family

ID=9898670

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001284242A Abandoned AU2001284242A1 (en) 2000-09-01 2001-08-31 Substituted pyrimidines as selective cyclooxygenase-2 inhibitors

Country Status (6)

Country Link
US (2) US7084148B2 (en)
EP (1) EP1313728A1 (en)
JP (1) JP2004507536A (en)
AU (1) AU2001284242A1 (en)
GB (1) GB0021494D0 (en)
WO (1) WO2002018374A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021494D0 (en) 2000-09-01 2000-10-18 Glaxo Group Ltd Chemical comkpounds
GB0112802D0 (en) 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
GB0112810D0 (en) 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
GB0112803D0 (en) * 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
GB0119477D0 (en) 2001-08-09 2001-10-03 Glaxo Group Ltd Pyrimidine derivatives
ATE325115T1 (en) * 2002-08-19 2006-06-15 Glaxo Group Ltd PYRIMIDINE DERIVATIVES AS SELECTIVE COX-2 INHIBITORS
UY27939A1 (en) 2002-08-21 2004-03-31 Glaxo Group Ltd COMPOUNDS
GB0221443D0 (en) * 2002-09-16 2002-10-23 Glaxo Group Ltd Pyridine derivates
GB0227443D0 (en) * 2002-11-25 2002-12-31 Glaxo Group Ltd Pyrimidine derivatives
UY29298A1 (en) 2004-12-23 2006-05-31 Glaxo Group Ltd COMPOUNDS
US20070161578A1 (en) * 2005-12-21 2007-07-12 Hwa Joyce J Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and/or H3 receptor antagonist/inverse agonist
GB0704407D0 (en) 2007-03-07 2007-04-18 Glaxo Group Ltd Compounds
US7943658B2 (en) 2007-07-23 2011-05-17 Bristol-Myers Squibb Company Indole indane amide compounds useful as CB2 agonists and method
DE102008015432A1 (en) * 2008-06-12 2009-12-17 Eberhard-Karls-Universität Tübingen Use of pirinixic acid derivatives to inhibit prostaglandin E2 synthesis
GB0813142D0 (en) 2008-07-17 2008-08-27 Glaxo Group Ltd Novel compounds
GB0813144D0 (en) 2008-07-17 2008-08-27 Glaxo Group Ltd Novel compounds
WO2011012622A1 (en) 2009-07-30 2011-02-03 Glaxo Group Limited Benzoxazinone derivatives for the treatment of glytl mediated disorders
WO2011023753A1 (en) 2009-08-27 2011-03-03 Glaxo Group Limited Benzoxazine derivatives as glycine transport inhibitors
GB201000685D0 (en) 2010-01-15 2010-03-03 Glaxo Group Ltd Novel compounds
GB201007789D0 (en) 2010-05-10 2010-06-23 Glaxo Group Ltd Novel Compound
GB201007791D0 (en) 2010-05-10 2010-06-23 Glaxo Group Ltd Novel compounds
US9115132B2 (en) 2010-07-09 2015-08-25 Convergence Pharmaceuticals Limited Tetrazole compounds as calcium channel blockers
US8933132B2 (en) 2011-01-19 2015-01-13 Convergence Pharmaceuticals Limited Tricyclic substituted benzenesulfonamide piperazine derivatives as CAV2.2 calcium channel blockers
GB201122113D0 (en) 2011-12-22 2012-02-01 Convergence Pharmaceuticals Novel compounds
GB201417497D0 (en) 2014-10-03 2014-11-19 Convergence Pharmaceuticals Novel use
GB201417499D0 (en) 2014-10-03 2014-11-19 Convergence Pharmaceuticals Novel use
GB201417500D0 (en) 2014-10-03 2014-11-19 Convergence Pharmaceuticals Novel use
AR122450A1 (en) * 2020-05-08 2022-09-14 Lilly Co Eli (TRIFLUORETHYL)PYRIMIDIN-2-AMINE COMPOUNDS

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149109A (en) 1962-02-20 1964-09-15 Searle & Co Certain 4-trifluoromethyl-2-(oxy/thio) pyrimidines
GB1121922A (en) 1966-06-17 1968-07-31 Ici Ltd Pyrimidine derivatives
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
KR100263817B1 (en) * 1993-11-30 2000-08-16 윌리암스 로저 에이 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
MX9701765A (en) 1994-09-09 1997-06-28 Nippon Shinyaku Co Ltd Heterocyclic derivative and medicine.
US5596008A (en) 1995-02-10 1997-01-21 G. D. Searle & Co. 3,4-Diaryl substituted pyridines for the treatment of inflammation
CA2224563A1 (en) 1995-06-12 1996-12-27 G.D. Searle & Co. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
US5700816A (en) 1995-06-12 1997-12-23 Isakson; Peter C. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
US6020343A (en) * 1995-10-13 2000-02-01 Merck Frosst Canada, Inc. (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
JPH09241161A (en) 1996-03-08 1997-09-16 Nippon Shinyaku Co Ltd Medicine
JPH09266197A (en) * 1996-03-28 1997-10-07 Mitsubishi Electric Corp Semiconductor device and its manufacture
CZ292843B6 (en) * 1996-07-18 2003-12-17 Merck Frosst Canada & Co. Pyridine derivative and pharmaceutical preparation in which it is comprised
RU2239429C2 (en) 1996-10-15 2004-11-10 Джи. Ди. Сирл Энд Ко. Method for applying cyclooxygenase-2 inhibitor for treatment and prophylaxis of neoplasia
AR038955A1 (en) 1996-12-05 2005-02-02 Amgen Inc PIRIMIDINONE AND PIRIDONA SUBSTITUTED COMPOUNDS AND METHODS FOR USE
CA2296014A1 (en) 1997-07-03 1999-01-14 Frank W. Hobbs Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists
EA002775B1 (en) * 1997-09-05 2002-08-29 Глаксо Груп Лимитед 2,3-diaryl-purazolo[1,5-b]pyridazines derivatives, their preparation and thir use as cycloxygenase 2 (cox-2) inhibitors
US5972986A (en) * 1997-10-14 1999-10-26 G.D. Searle & Co. Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
US6306866B1 (en) 1998-03-06 2001-10-23 American Cyanamid Company Use of aryl-substituted pyrimidines as insecticidal and acaricidal agents
DE19909541A1 (en) 1998-03-06 1999-10-14 American Cyanamid Co New pyrimidine derivatives useful as herbicides, especially for selective weed control
US6313072B1 (en) 1999-02-18 2001-11-06 American Cyanamid Company Herbicidal 2-aryloxy-or 2-arylthio-6-arylpyrimidines
EP1157025B1 (en) * 1999-02-27 2004-03-10 Glaxo Group Limited Pyrazolopyridines
GB9927844D0 (en) 1999-11-26 2000-01-26 Glaxo Group Ltd Chemical compounds
GB9930358D0 (en) * 1999-12-22 2000-02-09 Glaxo Group Ltd Process for the preparation of chemical compounds
GB0002312D0 (en) * 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
GB0002336D0 (en) * 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
GB0003224D0 (en) * 2000-02-11 2000-04-05 Glaxo Group Ltd Chemical compounds
GB0021494D0 (en) 2000-09-01 2000-10-18 Glaxo Group Ltd Chemical comkpounds
US6756498B2 (en) * 2001-04-27 2004-06-29 Smithkline Beecham Corporation Process for the preparation of chemical compounds
GB0112810D0 (en) 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
GB0112803D0 (en) 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
GB0112802D0 (en) 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
US6861249B1 (en) * 2002-04-09 2005-03-01 David Kent Microbial spray for animal waste

Also Published As

Publication number Publication date
EP1313728A1 (en) 2003-05-28
JP2004507536A (en) 2004-03-11
US7084148B2 (en) 2006-08-01
US20050282845A1 (en) 2005-12-22
WO2002018374A1 (en) 2002-03-07
US20040102466A1 (en) 2004-05-27
GB0021494D0 (en) 2000-10-18

Similar Documents

Publication Publication Date Title
AU2001284242A1 (en) Substituted pyrimidines as selective cyclooxygenase-2 inhibitors
AU2001258771A1 (en) -secretase inhibitors
AU2001237041A1 (en) Kinase inhibitors
AU2003279296A1 (en) Structural coupler
AU2001232036A1 (en) Pyrimidine derivatives as selective inhibitors of cox-2
AU2001296961A1 (en) 17-beta-hydroxysteroid dehydrogenase-ii inhibitors
AU4882101A (en) Mmp-12 inhibitors
AU2001262271A1 (en) Substituted iminoazines used as herbicides
AU2001234088A1 (en) TNF-alpha inhibitors
AU2001293373A1 (en) 2-guanidino-4-arylchinazolines as NHE-3 inhibitors
AU2002211663A1 (en) Nf-$g(k)b inhibitors
AU5248800A (en) Fading inhibitors
AU6381701A (en) Bisamidino compounds as nhe-3 inhibitors
AU2001229915A1 (en) Pyrazole compounds
AU2001244646A1 (en) Small drill
AU2002213978A1 (en) Substituted C-cyclohexylmethylamine derivatives
AU2002222627A1 (en) Tak1 inhibitors
AU2001242523A1 (en) Aminophenyl pyrimidone derivatives
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU2001254731A1 (en) Substituted phenyluracils
AU2001289937A1 (en) Substituted 1-aminobutan-3-ol derivatives
AU2002249809A1 (en) Potassium channel inhibitors
AU2001232245A1 (en) Tnf- alpha inhibitors
IL158799A0 (en) Pyrimidine derivatives useful as selective cox-2 inhibitors